Docetaxel second-line therapy in patients with advanced pancreatic cancer: a retrospective study. [electronic resource]
Producer: 20100830Description: 2905-9 p. digitalISSN:- 1791-7530
- Adenocarcinoma -- blood
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- CA-19-9 Antigen -- blood
- Capecitabine
- Deoxycytidine -- administration & dosage
- Docetaxel
- Erlotinib Hydrochloride
- Female
- Fluorouracil -- administration & dosage
- Humans
- Male
- Middle Aged
- Neoplasm Metastasis
- Pancreatic Neoplasms -- blood
- Quality of Life
- Quinazolines -- administration & dosage
- Retrospective Studies
- Salvage Therapy
- Taxoids -- administration & dosage
- Gemcitabine
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.